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Abstract  
Vulval skin disease is common in gynaecological practice. This review aims to enhance clinical 
skills in patient assessment, vulval examination and treatment of common benign vulval skin 
disease illustrated through cases. Basic treatments are often of benefit to the patient (e.g. use of 
emollients and topical steroids), but many patients have complex disease and can present with 
more than one condition so careful assessment and individualised management is essential. 
Understanding of when to refer onwards to a vulval specialist service is important to optimise 
clinical outcomes. Clinical outcomes to consider for all patients with vulval skin disease should 
include: (i) a reduction in symptoms (e.g. less itch, fewer flare-ups); (ii) an improvement in function 
(e.g. sexual function, mobility) and (iii) increased confidence in self-management (e.g. 
management of flare-ups and self-examination).  
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Vulval history 
A general history should be taken but additional history points are outlines in Table 1.  A detailed 
assessment of the presenting complaint is important, including its impact on the patient’s function. 
Irritancy from topical treatments especially over the counter products is common. Patients 
commonly perceive ‘low allergy’ products to be safe on vulval skin but they do contain potential 
irritants. Enquire about current and past treatments and response. Urine is an irritant, especially to 
genital skin, therefore asking about incontinence is important.  
Vulval examination 
 
A vulval examination should be carried out with the awareness of the patient’s possible discomfort 
and embarrassment. Examination should include all areas of the vulva, perineum and perianal 
areas. The patient should initially be in the dorsal position for vulval and perineal examination with 
adequate light. Turning the patient to the left lateral position to examine the perianal area may be 
useful.  
 
The normal vulva in an adult woman includes the mons pubis, inguinal folds, outer and inner labia 
(majora and minora), clitoris (body and hood), perineum, vestibule and anus (Figure 1). Hart’s line 
is the junction between the vestibule and the inner labia and marks change in epithelium type from 
mucosal type to stratified squamous. Digital and speculum examinations of the vagina may be 
appropriate to look for erosions, mucosal thickening, adhesions, and scarring1. Vulval pathology 
may be a manifestation of a general skin condition and therefore a complete examination including 
the umbilicus, natal cleft, oral cavity, eyes and mouth should be performed if relevant. This allows 
a more complete assessment of disease extent and diagnosis especially for diseases that are not 
solely restricted to the vulval region such as psoriasis, eczema, lichen sclerosus and erosive 
lichen planus. It is important to note that the classical appearances of skin conditions in non-
genital sites may not apply to the vulval area as it is a covered, moist environment. Useful 
terminology describing some of the lesions that may be seen in the vulval area are discussed in 
Table 2. 
 
Investigations 
 
Diagnostic vulval biopsy 
A 4mm Keyes punch biopsy is adequate and should ideally be carried out under local anaesthetic 
at the initial visit if indicated. Rarely vulval and vaginal lesions may due to an underlying 
immunobullous disease. These refer to a group of blistering skin condition with an autoimmune 
origin. The most common of these include pemphigus vulgaris and bullous pemphigoid. If 
suspected then please refer to the local vulval service for further assessment. In these cases a 
second biopsy from perilesional skin may be needed for immunofluoroscence. It is important to 
avoid crushing the epithelium when taking the biopsy as this can affect histological interpretation. 
A vulval biopsy is usually indicated for 1), asymmetrical pigmented lesions, 2) persistently eroded 
areas, 3) indurated and suspicious ulcerated areas, 4) when there is poor response to treatment 
following the initial diagnosis.  
 
The site selected for biopsy should be tissue-representative of the lesion or area of abnormality. 
This is usually at the edge of the lesion and should also include some normal tissue. The most 
central area may be inflamed or necrotic, which may give minimal tissue diagnosis because of the 
inflammation present.  
 
We would recommend a diagnostic biopsy only for initial assessment. If malignancy is suspected 
then a 4mm Keyes punch biopsy is acceptable or referral on to a gynaecological cancer team. An 
excisional biopsy can be problematic if the diagnosis is subsequently found to be cancer or VIN, 
as re-excision is often required. This can lead to further skin loss that might compromise function.  
Multiple mapping biopsies are indicated in cases of suspected multifocal disease to make a 
diagnosis and exclude invasion. This usually requires a general anaesthetic.  
 
Vaginal and vulval swabs  
Infection with candidiasis is a common cause for loss of symptom control in inflammatory 
dermatoses and may be a reason why lichen sclerosus appears initially well controlled with potent 
steroids and then flares. Minor degrees of skin trauma from scratching can produce infection. In 
addition, patients with diabetes may present with candidiasis. Occasionally, genital herpes can be 
a cause of vulval symptoms and a viral culture swab (which is different to a standard 
microbiological swab for bacterial culture and sensitivity) may be necessary. Genital herpes testing 
may not be possible in the standard gynaecology clinic so referral onto genito-urinary medicine 
services may be appropriate. Many patients feel antifungal treatment can help reduce symptoms 
but this may because of the soothing nature of the treatment that a bland emollient may give.  
 
Management 
 
General principles 
Initial principles of management are the same for all vulval skin conditions and a holistic approach 
is required. Good education, support and counselling are needed with extra time given to address 
the disease process, discussing general vulval care measures and managing expectations. It is 
useful to provide information leaflets, direct patients to relevant patient-oriented websites and write 
down instructions for applying topical agents(see ‘additional resources’ for sources of patient 
information). The use of a mirror or model in the clinic setting is helpful to show patients where to 
apply their topical treatments. 
Correct barrier function  
Most vulval skin conditions are characterised by skin or mucosal barrier breakdown as well as 
underlying inflammation. Correction of the epidermal barrier is important in helping to reduce 
inflammation. For washing, soap and other routine cleaning agents (e.g. wipes) should be 
avoided, as they are likely to act as irritants or allergens. Irritation from urinary and faecal 
incontinence needs to be addressed as these are a common cause of irritation and make 
underlying skin pathology worse. ‘Soap substitution’ with a bland cream or ointment based 
emollient is best for cleansing. The same agent can then be used as a moisturiser to both provide 
a barrier to the site and sooth inflamed skin. There is no preferred emollient to use and the best 
one is the one the patient will adhere to. Emollient creams (not ointments) can be placed in the 
fridge as this can help soothe the skin. 
 
The multidisciplinary team 
Some vulval problems are chronic, rare and difficult a multidisciplinary input may be required. 
Service provision can vary but most hospitals in the UK provide a local vulval clinic providing 
expert help. Members of vulval service might include dermatology, genito-urinary medicine, 
physiotherapy, pain management, psychosexual therapy, pathology and urogynaecology. The 
individual needs of the patient will vary.  
 
 
 
Case 1 
Vulval eczema 
 
A 40 year old female is referred with itching of the vulva. This has been getting worse for months 
and she finds herself scratching in her sleep, often resulting in bleeding. She had eczema as a 
child and gets occasional patches on the limbs when she is stressed or run down. She doesn’t use 
any topical therapies. On further questioning she uses wet wipes to clean herself after using the 
toilet. 
 
Figure 2. 
 
Examination Poorly defined erythema of the genitocrural skin, erosions due to excoriation of the 
inflamed skin and white thickening (lichenification) of the labia majora due to scratching. This 
appearance may be due to atopic eczema, or an external cause as in contact dermatitis. There is 
no loss of anatomy. Examine other areas for evidence of eczema, which would typically be the 
antecubital and popliteal fossae. 
 
Management: Moderate (e.g clobetasone butyrate 0.05%) or potent (e.g. mometasone furoate 
0.1%) topical steroid plus emollients to gain control of inflammation. It is very important to ask the 
patient details of products used to wash and wipe the area, to help exclude contact dermatitis. The 
wet wipes may be causing local irritation in this case. It is worthwhile advising the patient to use a 
bland emollient as a soap substitute and to discontinue wet wipes. 
 
Follow up: GP or dermatologist 
 
Contact dermatitis and when to think about patch testing 
 
Irritant contact dermatitis is common and is typically triggered by irritants eg soap, urine.  
Examination shows poorly defined erythema present where an irritant has been applied.  
Symptoms usually resolve when the irritant is removed. 
 
Allergic contact dermatitis is a delayed type (type IV) hypersensitivity reaction to allergens in the 
vulval area. Common examples include topical steroids, topical anaesthetics, fragrances, sodium 
lauryl sulphate and topical neomycin2. Clinically, the erythema may extend outside of the area 
where allergen has been applied. Figure 2 shows the appearance of vulval eczema that might be 
due to either atopic eczema or contact dermatitis. 
 
Patch testing is a measure of delayed type (type IV) hypersensitivity reaction. It is carried out 
under the supervision of a dermatologist and is indicated when allergic contact dermatitis is 
considered. During the process, potential allergens are placed on aluminium discs and applied to 
the patient’s back. These are removed and read at both 48 and 72 hours after application, to 
examine for a reaction. Allergic contact dermatitis is difficult to diagnose clinically and clinicians 
need to be aware of this condition when prescribing topical treatments such as steroids. 
Sensitisation leading to dermatitis can occur at any time and should be considered if symptoms 
initially well controlled with topical therapies subsequently flare. Patients should be initially referred 
to a vulval service or a dermatologist for an opinion if allergic contact dermatitis is suspected. 
Clinical history is very important to determine potential sensitising agents which can then be 
applied to the skin during the patch testing process.  
 
 
Case 2 
Vulval psoriasis 
 
This 60 year old lady has been referred with redness and soreness in the vulval area for many 
years. She uses a topical antifungal regularly which helps a little. She has a history of scalp 
psoriasis. 
 
Figure 3. 
 
Examination:  Well demarcated erythema surrounding the anogenital area with typical psoriatic 
plaques in surrounding skin. The genital plaque has typical scale in the perianal area, but lack of 
scale in the perineal and vulval areas. There is no scarring or loss of anatomy. 
Clinical assessment should include examination of ‘hidden sites’ for other signs of psoriasis eg. 
knees, elbows, umbilicus, scalp, ears, lower back and nails.  
 
Management: Moderate potency topical steroid plus emollients as recommended by NICE 
guidance. As the skin folds can become particularly macerated, there is a chance of secondary 
bacterial or fungal infection. A combination topical preparation (e.g clobetasone butyrate 
0.05%/oxytetracycline 3%/nystatin) may be helpful. Biopsy if the diagnosis is unsure. 
 
Follow up: Dermatologist or GP. Most gynaecologists may not feel comfortable in assessment 
and management. If so, patients should be referred on to a dermatologist. 
 
 
Case 3 
Lichen sclerosus 
 
A 68 year old lady describes itching and soreness of the vulva for many years, without any 
discharge. Her symptoms flare up intermittently and sometimes she finds underwear very 
uncomfortable. She has been treated for thrush several times by the GP, but her symptoms never 
fully clear. She finds the issue very embarrassing. She admits to washing the area three times a 
day with shower gel because she feels unclean.  
Figure 4. 
  
Examination: This is advanced lichen sclerosus (LS) with loss of normal anatomy (scarring). 
There are porcelain white papules and plaques and occasional ecchymoses (purpura). A typical 
early finding is ‘figure of 8’ appearance of erythema involving the vulval and perianal region. 
However, LS is often diagnosed quite late, therefore late findings of loss of normal anatomy, labial 
fusion and adhesions may be present at the first consultation. Occasionally papery white plaques 
can be found on other areas of the body. It is very unusual for LS to affect the mouth. The clinical 
findings are often adequate to establish a diagnosis. However, biopsy may need to be considered 
if there are any indurated areas or areas suspicious for VIN or malignancy.   
 
Management:  
A recent Cochrane systematic review showed there is reasonable randomised controlled trial 
evidence for the use of very potent topical steroids in lichen sclerosus3. The British Association of 
Dermatologists suggest the use of the very potent topical steroid, clobetasol proprionate 0.05% 
(Dermovate), over a three-month reducing course (suggested daily for one month, alternate days 
for month and twice a week maintenance)4. Long term maintenance with twice weekly therapy is 
recommended and the patient will use 30-60g topical steroid per year. Restoration of barrier 
function with a bland emollient is essential. This can be used as often as needed and can be used 
as a soap substitute. Posterior fourchette fissuring causing dyspareunia may require digital 
massage of the steroid into the fissure. Vaginal dilators and lubricants may also be useful. There is 
a small risk of cancer (less than 5% risk) so patients should be encouraged to self-examine on a 
regular (suggested monthly) basis. This patient should also be told to wash only once a day. 
Overwashing may perpetuate symptoms. 
 
Follow up: Gynaecologist, dermatologist or GP. Refer to vulval service for treatment resistant 
cases, complications of treatment, difficult disease and when associated with VIN. 
 
 
Use of topical steroids on the vulva 
Topical steroids reduce inflammation associated with skin diseases such as lichen planus, lichen 
sclerosus and eczema leading to improvement in symptoms and appearance. However, there are 
patient and physician concerns at the use of topical steroids due to worry about side-effects, 
particularly skin or mucosal atrophy, which can lead to under-treatment and less control of 
symptoms. It is important therefore to use the correct strength of topical steroid for the necessary 
length of time on the appropriate body site with the clear instructions to patient so that they can be 
confident in self-management and be reassured that when applied correctly ‘skin thinning’ is very 
unlikely and may occur when applied to the wrong area. Mucosal surfaces such as the vulval 
vestibule eg in lichen planus (see below) are remarkably resistant to steroid atrophy.  
 
In general, topical steroids should be used once-daily. There is no evidence to suggest that twice-
daily application is superior, although twice-daily has greater potential to cause side effects. 
Ointments are preferable to creams as they contain fewer constituents and therefore have a lower 
chance of causing irritation/contact allergy. Once control of inflammation and symptoms has been 
achieved, topical steroids should be reduced to the minimum frequency required to maintain 
remission. The concept of ‘weekend therapy’, that is, applying topical steroids on two consecutive 
days per week, is effective in atopic eczema patients and can extrapolated to chronic vulval 
diseases such as lichen sclerosus and lichen planus where long-term maintenance therapy is 
required. Topical steroids should only be used on affected areas to prevent side-effects in 
adjacent skin. Box 1 outlines reasons why there may be a failure to respond to topical steroid 
treatments. 
 
 
 
 
 
Case 4 
Erosive lichen planus with oral involvement 
 
A 30 year old female is referred with a longstanding history of vulval soreness and dyspareunia. 
She mentions that smears are very difficult. She uses emollients which help but her condition 
never settles. She also describes a sore mouth, for which she sees the dentist regularly.  
Figure 5, figure 6. 
 
 
 
Examination findings Two types of lichen can affect the vulva; ‘classical’ lichen planus gives 
violaceous, well demarcated plaques with overlying lacy white lines which usually affect the labia 
majora and surrounding skin. This can also affect extra-genital sites. Erosive lichen planus (as 
seen here) may present with ‘glazed’ erythema or erosions symmetrically distributed at vaginal 
introitus. Lacy white lines (Wickham’s striae) may be seen in surrounding skin and also in the 
buccal mucosa. There may be loss of anatomy. These patients can have vaginal involvement with 
significant vaginal stenosis so speculum examination is important. 
 
Management: There are currently no specific guidelines for lichen planus, but the standard 
practice is to use a similar regimen as for lichen sclerosus and case series evidence supports 
this5.The response rate to treatment is lower than for lichen sclerosus and there is a place for 
systemic therapies such as methotrexate in those with severe, recalcitrant or multisystem disease.   
 
 
Follow up: Dermatologist or gynaecologist. For classical type refer to vulval service for treatment- 
resistant cases and when associated with VIN.  Erosive lichen planus is difficult to treat so refer 
early to a vulval service. Consider referral to oral medicine if significant oral involvement. 
 
 
 
Conclusion 
Core competencies in vulval disease for the general gynaecologist should include being able to 
take a detailed patient history and examination, make a diagnosis and starting basic treatment. It 
is important to underpin the treatments with clear explanation to the patient on vulval care and the 
use of topical steroids to improve clinical outcomes. Patients with complex or rare conditions, or 
those who are treatment resistant, should be referred to a vulval service. 
 
Practice points 
 
• Take a thorough symptom and function history and perform a systematic examination 
• Describe vulval conditions in dermatological terminology to support the diagnosis 
• Avoid empirical prescriptions before there is clinical evidence to support the diagnosis. If 
you are not sure of the diagnosis please ask for advice 
• Provide written information and clear instructions to the patient where possible especially 
with regards the use of topical corticosteroids 
• Employ a low threshold for a vulval biopsy if there is any doubt about the diagnosis 
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Further resources; 
Dermnetnz: The Dermatology Resource www.dermnetnz.org 
British Society for the Study of Vulval Disease www.bssvd.org 
Online resource endorsed by the ISSVD http://vulvovaginaldisorders.com/ 
Online training course which is free to UK doctors to access  
www.e-lfh.org.uk/projects/dermatology/index.html 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
FIGURES 
 
Figure 1: Schematic representation of the normal adult vulva. Copyright  “Dawn Danby and Paul 
Waggoner”, c/o ISSVD 
 
Figure 2: Vulval eczema (dermatitis). Note poorly defined erythema of the genitocrural skin, 
erosions due to excoriation in the inflamed skin and white thickening (lichenification) of the labia 
majora due to scratching. This appearance may be due to atopic eczema, or an external cause as 
in contact dermatitis (either irritant or allergic contact dermatitis). 
 
Figure 3: Psoriasis affecting the female genitalia. Well demarcated erythema surrounding the 
anogenital area with typical psoriatic plaques in surrounding skin. The genital plaque has typical 
scale in the perianal area, but lack of scale in the perineal and vulval areas. 
 
Figure 4: Advanced vulval lichen sclerosus showing ecchymoses, atrophy and loss of normal 
anatomy. 
 
Figure 5: Desquamative gingivitis with evidence of Wickham’s striae in the buccal mucosae. 
Courtesy of Dr Ruth Murphy. 
 
Figure 6: Vulval erosive lichen planus

Table 1 – vulval history-taking points 
Question Reasoning 
What are the key symptoms and how 
severe are they?  
Important to be clear on the initial symptom. Itch can suggest skin disease or infection. Pain 
can be secondary to itching from skin damage through trauma. Vaginal discharge may suggest 
infection.  
How long has the woman been 
experiencing symptoms? 
Acute symptoms may indicate infections such vulvovaginal thrush or contact dermatitis. 
Chronic symptoms may be due to lichen sclerosus or lichen planus.  
What is the impact on the patient’s 
function? (‘How do the symptoms affect 
you?’ or ‘What do you miss as a result of 
the problem?’) 
Improvement in function (including sex) is an important clinical outcome. Functional impairment 
should be documented at every consultation 
What treatments have been tried before 
(including over the counter agents)? 
The history should explore failed treatments e.g. topical steroid frequency and amount as under 
usage with these treatments is common due to steroid phobia or a lack of understanding by the 
patient. Inappropriate topical treatments can exacerbate symptoms and potentially cause an 
irritant reaction. 
How is the patient cleaning the vulval 
area? 
Over-washing may lead to skin damage and further irritation.  
Are there any possible contacts with 
irritants e.g. soaps, shampoos, urine, and 
scented vaginal wipes?  
These are potential irritants and can damage the skin potentially causing inflammation. Urine 
and scented vaginal wipes are potent skin irritants. 
Are symptoms stress related? In lichen simplex, itching is classically worse at times of stress. Many inflammatory skin 
conditions may flare during stressful life events. 
Is there any systemic illness? For example, diabetes, renal failure, anaemia (these may all be a cause of itch), or 
autoimmune conditions (higher chance of systemic autoimmunity in lichen sclerosus or erosive 
lichen planus). A family history of autoimmunity should also be asked..= 
Are there any other skin conditions 
present? 
Skin disease at other skin sites may provide clues to the vulval diagnosis. For example, 
eczema or psoriasis. These may be very obvious, however signs may be subtle, for example 
psoriasis is sometimes hidden as cracking behind the ears, a scaly scalp or umbilical 
erythema) 
 
 
 
Table 2: Terminology of lesions that may be seen in the vulval area 
 
Lesion 
terminology 
Description Example 
Fissure A thin ‘hairline’ crack in the skin surface due to excessive 
dryness 
Psoriasis and lichen sclerosus  
Excoriation Scratch mark, may be single or multiple May be seen in any itchy skin 
condition e.g. atopic eczema, 
lichen sclerosus 
Erosion A shallow denuded area due to loss of the epidermis (surface 
layer of skin) 
Erosive lichen planus 
Ulcer Full thickness loss of the epidermis (top layer of skin) +/- dermis Aphthous ulceration 
Macule Flat area of colour change Vulval melanosis 
Ecchymosis (subcutaneous 
purpura) seen in lichen 
sclerosus 
Nodule Large palpable lesion greater than 0.5 cm in diameter Squamous cell carcinoma, 
Scabies 
Papule Small palpable lesion less than 0.5cm in diameter Genital warts 
Molluscum contagiosum 
Seborrhoeic keratosis 
Plaque A palpable flat lesion greater than 0.5 cm diameter. It may be 
elevated or may be a thickened area without being visibly raised 
above the skin surface 
Vulval Intraepithelial Neoplasia 
Squamous cell carcinoma 
Large seborrheic keratosis 
Vesicle Small fluid filled blister less than 0.5cm diameter Bullous pemphigoid 
Lichenification An accentuation of skin markings commonly associated with 
thickening of epidermis usually caused by scratching or rubbing 
Lichen simplex 
 
 
 
 
 
 
 
. 
 
 
Box 1 – Reasons why there may be a failure to respond to topical steroid treatments within vulval skin conditions 
• Continued exposure to irritants – eg urine or faeces, external products such as wipes or non-prescribed topical treatments and over 
washing with water can all contribute towards irritation and ongoing symptoms. 
 
• Poor adherence to prescribed treatment regimen –The patient should be advised to apply the topical steroid in terms of the fingertip unit 
(A fingertip is from the very end of the finger to the first crease in the finger. It does NOT mean a blob on the fingertip). The number of 
fingertip units required is usually one to two but is specifically tailored to the patient depending upon surface area affected by the 
condition. 
 
• Inaccurate placement of topical steroid – the patient may be applying the topical treatment to an unaffected area. Especially common if the 
patient is elderly and unable to use a mirror to see what they are doing. 
  
• Incorrect diagnosis – if adherence and skin care practices are assessed as adequate, it may be that the diagnosis given is incorrect. An 
allergic contact dermatitis to topical treatments may have occurred (see section on Patch Testing) or there may be pre-malignant or 
malignant change in the affected area. If there is any concern a biopsy should be taken 
 
• An inappropriate and/or weak steroid has been prescribed eg 1% hydrocortisone. Reducing the potency of the steroid ointment is not 
usually practiced and it is more usual to reduce the frequency of application of the very potent steroid. 
  
• Superimposed infection – eg candidiasis. 
 
